Drug approval decision times, international reference pricing and strategic launches of new drugs
Nicolas Houy and
Izabela Jelovac
Working Papers from HAL
Abstract:
This paper analyzes how drug approval procedures influence the incentives of pharmaceutical firms to launch new drugs in the presence of international reference pricing. First, we show that the set of countries in which a firm commercializes a new drug is larger when countries do not approve this new drug simultaneously. We also show that a firm's best response to international reference pricing is to never launch a new drug sequentially as long as the difference in drug approval times between countries is small enough. Furthermore, we show that a firm's incentives to launch a new drug in one or another country are the same if the drug approval times are identical across countries or if the difference between approval times are small enough. However, we show that these incentives can change if the approval times differences across countries are large enough.
Keywords: Drug launch timing; sequential launching; marketing authorization; international reference pricing (search for similar items in EconPapers)
Date: 2014
Note: View the original document on HAL open archive server: https://shs.hal.science/halshs-01072741v1
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)
Downloads: (external link)
https://shs.hal.science/halshs-01072741v1/document (application/pdf)
Related works:
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2017)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2015)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2015)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2015)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2015)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2014) 
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2014)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:hal:wpaper:halshs-01072741
Access Statistics for this paper
More papers in Working Papers from HAL
Bibliographic data for series maintained by CCSD ().